Protagonist Therapeutics, Inc. (PTGX)
NASDAQ·Healthcare·Biotechnology
$136.52
+3.21%
Mkt Cap $8.72B
Analyst Ratings
Buy
11
Hold
1
Sell
0
Price Target (18 analysts)
$123.25
Range $110.00 – $145.00
Implied Upside
-9.7%
Consensus $123.25 vs current $136.52